Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 14, 2014Clinical Cancer Research

Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53 -Mutant Tumors and Identifies NRAS as an Oncogenic Driver

View Full Paper
Ask AI
Bookmark
Share

Authors

CECatherine EmmanuelThe University of SydneyYCYoke-Eng ChiewWestmead HospitalJGJoshy GeorgeJackson Laboratory

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Emmanuel et al. (2014) studied this question.

synapsesocial.com/papers/6aa315a75ab09ae4dd1f129ehttps://doi.org/10.1158/1078-0432.ccr-14-1292
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Screening for genetic abnormalities involved in ovarian carcinogenesis using retroviral expression libraries2009 · 18 citations
  2. 2affy—analysis of Affymetrix GeneChip data at the probe level2004 · 5,519 citations
  3. 3High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort2013 · 66 citations
  4. 4High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies2008 · 206 citations
  5. 5The distal fallopian tube: a new model for pelvic serous carcinogenesis2007 · 515 citations